| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 05/26/2004 | CN1500097A Human monoclonal antibodies to FC Alpha receptor (CD89) |
| 05/26/2004 | CN1500082A Cyano-5ubstituted dihydropyrimidine compounds and their use to treat diseases |
| 05/26/2004 | CN1499979A Compsns. contg active fraction isolates from hedyotis diffusae and methods of use |
| 05/26/2004 | CN1499969A pharmaceutical formulation contg. pyrazolo[4,3-D] pyrimidine and nitrates or thienopyrimidines and nitrates |
| 05/26/2004 | CN1498633A Oral liquid for treating ophthalmic diseases |
| 05/26/2004 | CN1498624A Puerarin gelation for eye use and prepn. method |
| 05/26/2004 | CN1151133C Anthranilic acid amides and use thereof as medicaments |
| 05/26/2004 | CN1150925C Chinese Patent medicine for curing deafness |
| 05/25/2004 | US6740772 Pgd2 agonists; sleep inducing action; intracerebral transition; stability |
| 05/25/2004 | US6740746 Nucleotide sequences coding polypeptide for use in the treatment and detection of of cancer, coronary or cerebrovascular, hypertensive, diabetic, arthritic and vision defects |
| 05/25/2004 | US6740738 Antibodies binding to polypeptides encoded by the genes |
| 05/25/2004 | US6740681 Inhibiting angiogenesis and/or inflammation |
| 05/25/2004 | US6740676 Treating diseases controlled by or responsive to retinoic acid |
| 05/25/2004 | US6740674 Administering formulation comprising proteasome inhibitor in carrier for therapy of dry eye disorder |
| 05/25/2004 | US6740666 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 05/25/2004 | US6740655 3',5'-cyclic nucleotide phosphodiesterase 4-specific inhibitors reduce eosinophil influx to the lungs; side effect reduction; antiinflammatory agent; antiallergens; respiratory system disorders, especially asthma |
| 05/25/2004 | US6740652 Topical administration of an ophthalmologically effective amount of an oxazolidinone derivative |
| 05/25/2004 | US6740647 Amidines and hydroxyamidine derivatives |
| 05/25/2004 | US6740325 Peptide-based vaccine for influenza |
| 05/25/2004 | CA2278782C Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders |
| 05/25/2004 | CA2115170C Imidazolyl-alkenoic acids |
| 05/21/2004 | WO2004041859A2 Peptide fragments of the harp factor inhibiting angiogenesis |
| 05/21/2004 | WO2004041266A1 Receptor function controlling agent |
| 05/21/2004 | WO2004041134A1 Eyelid margin wipes comprising chemical means for temperature adjustment |
| 05/21/2004 | WO2003101455A3 Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use |
| 05/21/2004 | WO2003088900A3 Solid forms of salts with tyrosine kinase activity |
| 05/21/2004 | WO2003084935A3 Diaryl pyrimidinone derivatives useful for the treatment of inflammation and immunogolical diseases |
| 05/21/2004 | WO2003080105A3 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof |
| 05/21/2004 | CA2505322A1 Receptor function regulator |
| 05/21/2004 | CA2504270A1 Peptide fragments of the harp factor inhibiting angiogenesis |
| 05/20/2004 | US20040097867 Systems and methods for treating patients with processed lipoaspirate cells |
| 05/20/2004 | US20040097733 Bicyclic aromatic or heteroaromatic-amine compounds; Regulators of cell proliferation and differentiation; useful for treating skin related diseases; retinoid antagonist or retinoid inverse agonist-like biological activity |
| 05/20/2004 | US20040097592 Adding nonionic surfactant and antioxidant; preventing decomposition and container adsorption of prostaglandin derivative in ophthalmic solution |
| 05/20/2004 | US20040097589 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 05/20/2004 | US20040097585 4-(2,6-difluorophenyl)-4-oxobutyric acid and derivatives; milder side effects; insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis, arteriosclerosis |
| 05/20/2004 | US20040097575 For therapy of glaucoma and other conditions which leads to elevated intraoccular pressure in the eye of a patient; to provide neuroprotective effect to the eye of mammals |
| 05/20/2004 | US20040097569 Aryl substituted hydantoin compounds and their use as sodium channel blockers |
| 05/20/2004 | US20040097564 Method and compounds for treating glaucoma VI |
| 05/20/2004 | US20040097563 4-6-Diphenyl pyridine derivatives as antiinflammatory agents |
| 05/20/2004 | US20040097539 Hsp inductor |
| 05/20/2004 | US20040097508 Novel heterocyclically substituted amides, their preparation and use |
| 05/20/2004 | US20040097506 Pyrimidine derivatives for inhibition of cell proliferation |
| 05/20/2004 | US20040097495 Method for treating fibrotic diseases or other indications IIIC |
| 05/20/2004 | US20040097494 For use as nitric oxide synthase inhibitors |
| 05/20/2004 | US20040097487 To inhibits matrix metalloprotease activity |
| 05/20/2004 | US20040097478 Remedies for retina and choroid diseases containing steroids as the active ingredient |
| 05/20/2004 | US20040097474 Administering formulation comprising anti-allergy agent selected from emedastine and olopatadine and steroid selected from the group consisting of fluticasone, mometasone, budesonide and beclomethasone for therapy of allergic rhinitis |
| 05/20/2004 | US20040097465 ll-12 expression controlling agents |
| 05/20/2004 | US20040097434 For therapy of inflammatory diseases and conditions in humans and animals |
| 05/20/2004 | US20040097425 Peptide compounds |
| 05/20/2004 | US20040097407 Method for the synthesis of compounds of formula I and their uses thereof |
| 05/20/2004 | US20040096888 Comprises nucleotide sequences coding cyclin dependent kinase (PELOTA) for diagnosis, treatment, prognosis and prevention of cell proliferative, cardoivascular, inflammatory, arthritic disorders |
| 05/20/2004 | US20040096526 Using plant extracts mixtures; extraction, filtration, spray drying; beverages |
| 05/20/2004 | US20040096513 Systemically minimizing the inflammatory effects of TNF- alpha are disclosed. The compositions include particles of bioactive glass with a particle size less than about 20 mu m, alone or in combination with anti-inflammatory agents and |
| 05/20/2004 | US20040096431 Providing a tissue removal system; removing adipose tissue from a patient using the tissue removal system, the adipose tissue having a concentration of stem cells; processing at least a part of the adipose tissue to obtain a concentration |
| 05/19/2004 | EP1419780A1 Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of senile dementia and Alzheimer's disease |
| 05/19/2004 | EP1419769A1 Therapeutic and dietary compositions containing essential fatty acids and bioactive disulphides |
| 05/19/2004 | EP1419264A2 Kinases and phosphatases |
| 05/19/2004 | EP1419256A2 Conjugates for the modulation of immune responses |
| 05/19/2004 | EP1419162A1 Substituted-aryl 7-aza 2.2.1]bicycloheptanes for the treatment of disease |
| 05/19/2004 | EP1419161A1 Substituted-heteroaryl-7-aza 2.2.1]bicycloheptanes for the treatment of disease |
| 05/19/2004 | EP1419159A1 1-alkyl 0r 1-cycloalkyltriazolo 4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors |
| 05/19/2004 | EP1419158A1 Pteridinone derivatives as modulators of chemokine receptor activity |
| 05/19/2004 | EP1419150A2 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 05/19/2004 | EP1419149A1 Benzo g] quinoline derivatives for treating glaucoma and myopia |
| 05/19/2004 | EP1418931A1 New drug |
| 05/19/2004 | EP1418930A2 Mucosal repair by tff2 peptides |
| 05/19/2004 | EP1418924A2 Single dose azithromycin for treating respiratory infections |
| 05/19/2004 | EP1418922A1 Compositions comprising negatively charched phospholipids for treatment and/or prevention of macular degeneration and method for its manufacture |
| 05/19/2004 | EP1418919A2 The use of 5 fluorourcil, delivered by inotophoresis as an inhibitor of cell proliferation in the eye, bulbar and palpebral conjunctiva, eyelid, peri-orbital soft tissues and skin |
| 05/19/2004 | EP1418911A1 2,4,5-trisubstituted thiazolyl derivatives ant their antiinflammatory activity |
| 05/19/2004 | EP1418903A2 Prostanoids augment ocular drug penetration |
| 05/19/2004 | EP1418881A2 Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide |
| 05/19/2004 | EP1418864A1 Method and intra sclera implant for treatment of glaucoma and presbyopia |
| 05/19/2004 | EP1261357A4 Isolation and transplantation of retinal stem cells |
| 05/19/2004 | EP1259505B1 Novel 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same |
| 05/19/2004 | EP1235824B1 Vitamin d analogues |
| 05/19/2004 | EP1220855B1 Anhydrous salt |
| 05/19/2004 | EP1220849B1 Bicyclic compounds composition and method for stabilizing the same |
| 05/19/2004 | EP1147084B1 Phenylsulphonyl derivatives as 5-ht receptor ligands |
| 05/19/2004 | EP1034164B1 Substituted beta-alanine derivatives as cell adhesion inhibitors |
| 05/19/2004 | EP1021553B1 Eukaryotic gene expression cassette and uses thereof |
| 05/19/2004 | EP1009738B1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 05/19/2004 | EP1000051B1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/19/2004 | DE10236564A1 Verwendung von papaverinartigem Vasodilatator und pharmazeutische Zusammensetzung Use of papaverinartigem vasodilator and pharmaceutical composition |
| 05/19/2004 | DE10048715A1 Verwendung von Aminosäure zur Behandlung von Schmerz Using amino acid for treating pain |
| 05/19/2004 | CN1498219A Polymorph forms of N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b] quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl) acetamide |
| 05/19/2004 | CN1498218A Imidazo-pyrimidine derivatives as ligands for GABA receptors |
| 05/19/2004 | CN1498217A Heterocyclic compounds for aging-related and diabetic vascular complications |
| 05/19/2004 | CN1498214A Bicyclic guanidine derivatives and therapeutic uses thereof |
| 05/19/2004 | CN1498104A Novel application of peptide class of compound for treating allodynia or other different types of chronic or phantom pain |
| 05/19/2004 | CN1150205C 3-mercaptoacetylamino-1,5-subsd.2-oxo-axepon derivatives useful as inhibitor of metrix metalloproteinaes |
| 05/19/2004 | CN1150192C Piperidines as CCR5 modulators |
| 05/19/2004 | CN1150180C Diarylbenzopyran derivatives as cycloosygenase-2 inhibitors |
| 05/19/2004 | CN1150011C 'Qingzhang Mingmu' pills for clearing eyes and its preparation method |
| 05/18/2004 | US6737507 Antiangiogenic peptides and compositions thereof |
| 05/18/2004 | US6737422 Voltage-dependent |
| 05/18/2004 | US6737418 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof |
| 05/18/2004 | US6737399 Using histacalin protein isolated from ticks |
| 05/18/2004 | US6737246 Incubating substance with a mixture comprising a protein, marker substrate, which binds to the catalytic domain and is converted by the protein, and substrate; determining whether the marker substrate is converted by the protein |